日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Coverage of actionable alterations in non-small cell lung cancer by hybrid capture-based FoundationOne®CDx compared with amplicon-based OncomineDX

与基于扩增子的OncomineDX相比,基于杂交捕获的FoundationOne®CDx对非小细胞肺癌中可操作性改变的覆盖范围

Chen, Kuei-Ting; Sethunath, Vidyalakshmi; Ebot, Ericka; Decker, Brennan; Gasco, Amaya; Ross, Jeffrey S; Heilmann, Andreas M; Smith, Serenedy; Lofgren, Katherine; Huang, Richard S P

High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer

高 FOXA1 水平会诱导 ER 转录重编程、促转移分泌组以及内分泌抗性乳腺癌的转移

Xiaoyong Fu, Resel Pereira, Chia-Chia Liu, Carmine De Angelis, Martin J Shea, Sarmistha Nanda, Lanfang Qin, Tamika Mitchell, Maria L Cataldo, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Mario Giuliano, Carolina Gutierrez, Balázs Győrffy, Meghana V Trivedi, Ofir Cohen, Nikhil Wagle, Agostina Na

A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer

基因组规模的 CRISPR 筛选揭示了 PRMT1 是前列腺癌中雄激素受体信号传导的关键调节剂

Stephen Tang, Vidyalakshmi Sethunath, Nebiyou Y Metaferia, Marina F Nogueira, Daniel S Gallant, Emma R Garner, Lauren A Lairson, Christopher M Penney, Jiao Li, Maya K Gelbard, Sarah Abou Alaiwi, Ji-Heui Seo, Justin H Hwang, Craig A Strathdee, Sylvan C Baca, Shatha AbuHammad, Xiaoyang Zhang, John G D

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

IFN信号通路激活与ER阳性乳腺癌中CDK4/6抑制剂耐药性和免疫检查点激活相关

De Angelis, Carmine; Fu, Xiaoyong; Cataldo, Maria Letizia; Nardone, Agostina; Pereira, Resel; Veeraraghavan, Jamunarani; Nanda, Sarmistha; Qin, Lanfang; Sethunath, Vidyalakshmi; Wang, Tao; Hilsenbeck, Susan G; Benelli, Matteo; Migliaccio, Ilenia; Guarducci, Cristina; Malorni, Luca; Litchfield, Lacey M; Liu, Jiangang; Donaldson, Joshua; Selenica, Pier; Brown, David N; Weigelt, Britta; Reis-Filho, Jorge S; Park, Ben H; Hurvitz, Sara A; Slamon, Dennis J; Rimawi, Mothaffar F; Jansen, Valerie M; Jeselsohn, Rinath; Osborne, C Kent; Schiff, Rachel

Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models

在 HER2 阳性乳腺癌异种移植模型中,Neratinib 联合曲妥珠单抗优于帕妥珠单抗联合曲妥珠单抗

Jamunarani Veeraraghavan, Carolina Gutierrez, Vidyalakshmi Sethunath, Sepideh Mehravaran, Mario Giuliano, Martin J Shea, Tamika Mitchell, Tao Wang, Sarmistha Nanda, Resel Pereira, Robert Davis, Kristina Goutsouliak, Lanfang Qin, Carmine De Angelis, Irmina Diala, Alshad S Lalani, Chandandeep Nagi, Su

Towards personalized treatment for early stage HER2-positive breast cancer

迈向早期HER2阳性乳腺癌的个体化治疗

Goutsouliak, Kristina; Veeraraghavan, Jamunarani; Sethunath, Vidyalakshmi; De Angelis, Carmine; Osborne, C Kent; Rimawi, Mothaffar F; Schiff, Rachel

Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy

评估肿瘤免疫浸润在接受新辅助抗HER2治疗(未接受化疗)的HER2阳性乳腺癌患者中的预测作用

De Angelis, Carmine; Nagi, Chandandeep; Hoyt, Cliff C; Liu, Linying; Roman, Kristin; Wang, Chichung; Zheng, Yi; Veeraraghavan, Jamunarani; Sethunath, Vidyalakshmi; Nuciforo, Paolo; Wang, Tao; Tsimelzon, Anna; Mao, Sufeng; Hilsenbeck, Susan G; Trivedi, Meghana V; Cataldo, Maria Letizia; Pavlick, Anne; Wolff, Antonio C; Weigelt, Britta; Reis-Filho, Jorge S; Prat, Aleix; Gutierrez, Carolina; Osborne, Charles Kent; Rimawi, Mothaffar F; Schiff, Rachel

Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD

非酒精性脂肪性肝病中肝纤维化的自动定量和结构模式检测

Gawrieh, Samer; Sethunath, Deepak; Cummings, Oscar W; Kleiner, David E; Vuppalanchi, Raj; Chalasani, Naga; Tuceryan, Mihran

Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer

靶向甲羟戊酸途径克服乳腺癌获得性抗HER2治疗耐药性

Sethunath, Vidyalakshmi; Hu, Huizhong; De Angelis, Carmine; Veeraraghavan, Jamunarani; Qin, Lanfang; Wang, Nicholas; Simon, Lukas M; Wang, Tao; Fu, Xiaoyong; Nardone, Agostina; Pereira, Resel; Nanda, Sarmistha; Griffith, Obi L; Tsimelzon, Anna; Shaw, Chad; Chamness, Gary C; Reis-Filho, Jorge S; Weigelt, Britta; Heiser, Laura M; Hilsenbeck, Susan G; Huang, Shixia; Rimawi, Mothaffar F; Gray, Joe W; Osborne, C Kent; Schiff, Rachel

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

FOXA1 上调促进内分泌抗性乳腺癌中的增强子和转录重编程

Xiaoyong Fu, Resel Pereira, Carmine De Angelis, Jamunarani Veeraraghavan, Sarmistha Nanda, Lanfang Qin, Maria L Cataldo, Vidyalakshmi Sethunath, Sepideh Mehravaran, Carolina Gutierrez, Gary C Chamness, Qin Feng, Bert W O'Malley, Pier Selenica, Britta Weigelt, Jorge S Reis-Filho, Ofir Cohen, Nikhil W